| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human atonal homolog 1 (Drosophila) (ATOH1), full length from ORIGENE TECHNOLOGIES | TP760362 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, Ca++ transporting, plasma membrane 4 (ATP2B4), transcript variant 2 from ORIGENE TECHNOLOGIES | TP313835 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 (ATP2A1), transcript variant a from ORIGENE TECHNOLOGIES | TP314911 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, Ca++ transporting, ubiquitous (ATP2A3), transcript variant 5 from ORIGENE TECHNOLOGIES | TP317328 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, class I, type 8B, member 2 (ATP8B2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP315926 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase family, AAA domain containing 4 (ATAD4) from ORIGENE TECHNOLOGIES | TP302629 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 (ATP6V1B1) from ORIGENE TECHNOLOGIES | TP309462 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, Cu++ transporting, beta polypeptide (ATP7B), transcript variant 1 from ORIGENE TECHNOLOGIES | TP323635 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c (ATP6V0C) from ORIGENE TECHNOLOGIES | TP303652 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 (ATP6V1B2) from ORIGENE TECHNOLOGIES | TP305447 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 (ATP6V1C2), transcript variant 2, full length from ORIGENE TECHNOLOGIES | TP760121 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 (ATP6V1C1) from ORIGENE TECHNOLOGIES | TP303149 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 (ATP6V0D1) from ORIGENE TECHNOLOGIES | TP303498 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 (ATP6V0D2) from ORIGENE TECHNOLOGIES | TP309007 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 (ATP6V0E1) from ORIGENE TECHNOLOGIES | TP315618 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 (ATP6V1E1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP301267 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 (ATP6V1G1) from ORIGENE TECHNOLOGIES | TP303317 | 20 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol glycan anchor biosynthesis, class T (PIGT), transcript variant 3 from ORIGENE TECHNOLOGIES | LY433206 | 100 ug | ORIGENE TECHNOLOGIES |
| Human ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F (ATP6V1F) from ORIGENE TECHNOLOGIES | TP310728 | 20 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol glycan anchor biosynthesis, class T (PIGT), transcript variant 4 from ORIGENE TECHNOLOGIES | LY433142 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol glycan anchor biosynthesis, class V (PIGV) from ORIGENE TECHNOLOGIES | LY413509 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol glycan anchor biosynthesis, class Y (PIGY), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421007 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol glycan anchor biosynthesis, class Y (PIGY), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409866 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol glycan anchor biosynthesis, class X (PIGX), transcript variant 2 from ORIGENE TECHNOLOGIES | LY413484 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol 4-kinase, catalytic, alpha (PI4KA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400937 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol glycan anchor biosynthesis, class Z (PIGZ) from ORIGENE TECHNOLOGIES | LY410861 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol 4-kinase type 2 alpha (PI4K2A) from ORIGENE TECHNOLOGIES | LY413054 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-4-phosphate 5-kinase-like 1 (PIP5KL1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY427600 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-4-phosphate 5-kinase-like 1 (PIP5KL1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406338 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol 4-kinase type 2 beta (PI4K2B) from ORIGENE TECHNOLOGIES | LY402666 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha (PIP5K1A), transcript variant 3 from ORIGENE TECHNOLOGIES | LY427639 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha (PIP5K1A), transcript variant 1 from ORIGENE TECHNOLOGIES | LY427641 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-4-phosphate 5-kinase, type I, beta (PIP5K1B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY418599 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma (PIP5K1C) from ORIGENE TECHNOLOGIES | LY402206 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha (PIP5K1A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY418598 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-5-phosphate 4-kinase, type II, alpha (PIP4K2A) from ORIGENE TECHNOLOGIES | LY417590 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-5-phosphate 4-kinase, type II, gamma (PIP4K2C), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411069 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-5-phosphate 4-kinase, type II, gamma (PIP4K2C), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431365 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-5-phosphate 4-kinase, type II, beta (PIP4K2B) from ORIGENE TECHNOLOGIES | LY418600 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-5-phosphate 4-kinase, type II, gamma (PIP4K2C), transcript variant 3 from ORIGENE TECHNOLOGIES | LY431351 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-specific phospholipase C, X domain containing 3 (PLCXD3) from ORIGENE TECHNOLOGIES | LY423588 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-5-phosphate 4-kinase, type II, gamma (PIP4K2C), transcript variant 4 from ORIGENE TECHNOLOGIES | LY431328 | 100 ug | ORIGENE TECHNOLOGIES |
| Phosphatidylinositol-specific phospholipase C, X domain containing 1 (PLCXD1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413089 | 100 ug | ORIGENE TECHNOLOGIES |
| CCT6B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405267 | 1 kit | ORIGENE TECHNOLOGIES |
| CCT6A Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH312330 | 10 ug | ORIGENE TECHNOLOGIES |
| CCT3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403580 | 1 kit | ORIGENE TECHNOLOGIES |
| Cct6b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502854 | 1 kit | ORIGENE TECHNOLOGIES |
| CCT6B Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305267 | 10 ug | ORIGENE TECHNOLOGIES |
| CCT5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN404358 | 1 kit | ORIGENE TECHNOLOGIES |
| CCT8 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410044 | 1 kit | ORIGENE TECHNOLOGIES |